Diabetes is described by some as the worst global health threat of the 21st Century. There are now 415 million people in the world with diabetes according to the IDF. The World Health Organization WHO estimated the global prevalence of diabetes in 2000 at 171 million people, expecting the number to rise to 366 million by 2030. However by 2015 there were already 415 million people with diabetes, far above what was predicted in 2000 in half the time expected. Usage of good quality diagnostics is essential to monitor at risk populations at an early stage, before significant damage has accumulated and early enough to enable lifestyle changes that can slow or stop the onset of Type 2 diabetes.
Rapid Labs offer ELISA tests for Insulin, C-Peptide, GAD, Anti Insulin (IIA) and Anti Protein/Tyrosine (IA2)